Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Lutfi F"'
Autor:
Ahmed N; University of Kansas Cancer Center, Westwood, Kansas, United States., Wesson W; University of Kansas Cancer Center, Westwood, Kansas, United States., Lutfi F; University of Kansas Medical Center, Westwood, Kansas, United States., Porter DL; University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States., Bachanova V; University of Minnesota, Minneapolis, Minnesota, United States., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Perales MA; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Maziarz RT; Knight Cancer Institute, Portland, Oregon, United States., Brower J; University of Pennsylvania, Philadelphia, Pennsylvania, United States., Shah GL; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Chen AI; Knight Cancer Institute, Oregon Health & Science University., Oluwole OO; Vanderbilt University Medical Center, Nashville, Tennessee, United States., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States., Bishop MR; University of Chicago, Chicago, Illinois, United States., McGuirk JP; University of Kansas Cancer Center, Westwood, Kansas, United States., Riedell PA; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.
Autor:
Khattab TZ; Department of Orthodontics and Dentofacial Orthopedics, University of Hama Dental School, Hama, Syria. Tariq_khattab@hotmail.com., Lutfi F; Private Practice of Orthodontics in Abu Dhabi, United Arab Emirates., Alzarif W; National Hospital of Hama, Hama, Syria., Almallah D; Department of Orthodontics and Dentofacial Orthopedics, University of Hama Dental School, Hama, Syria., Alawad T; Department of Orthodontics and Dentofacial Orthopedics, University of Hama Dental School, Hama, Syria.
Publikováno v:
Journal of clinical orthodontics : JCO [J Clin Orthod] 2024 Jul; Vol. 58 (7), pp. 428-438.
Autor:
McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Khan MA; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Mudaranthakam DP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Lutfi F; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Bansal R; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Abdelhakim H; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Gorsline C; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Shoemaker DM; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Abhyankar SH; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America. Electronic address: mmushtaq@kumc.edu.
Publikováno v:
Transplant immunology [Transpl Immunol] 2024 Jun; Vol. 84, pp. 102039. Date of Electronic Publication: 2024 Mar 19.
Autor:
Lutfi F; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Tun AM; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Hoffmann M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.
Publikováno v:
Annals of palliative medicine [Ann Palliat Med] 2024 May; Vol. 13 (3), pp. 729-732. Date of Electronic Publication: 2024 Apr 18.
Autor:
Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Lutfi F; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Al-Ramahi JS; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Li K; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Bansal R; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Abdelhakim H; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Abhyankar SH; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Apr; Vol. 65 (4), pp. 493-502. Date of Electronic Publication: 2024 Jan 02.
Publikováno v:
AIP Conference Proceedings; 2023, Vol. 2604 Issue 1, p1-5, 5p
Publikováno v:
AIP Conference Proceedings; 2023, Vol. 2604 Issue 1, p1-6, 6p
Autor:
Al-Ramahi JS; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Shahzad M; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Nguyen A; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Li K; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Amin MK; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Lutfi F; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., DeJarnette S; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Chaudhary SG; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Bansal R; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Abdelhakim H; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Shune L; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Singh AK; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Abhyankar SH; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA., Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA. mmushtaq@kumc.edu.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Jan; Vol. 59 (1), pp. 134-137. Date of Electronic Publication: 2023 Oct 13.
Publikováno v:
AIP Conference Proceedings.
Publikováno v:
AIP Conference Proceedings.